Community Welfare Initiatives, Upcoming Results, Completed Expansions, Equity Offerings, and Acquisitions - Analyst Notes on Brookdale, WellCare, IDEXX, Kindred and Spectranetics

NEW YORK, July 3, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Brookdale Senior Living, Inc. (NYSE: BKD), WellCare Health Plans, Inc. (NYSE: WCG), IDEXX Laboratories, Inc. (NASDAQ: IDXX), Kindred Healthcare, Inc. (NYSE: KND) and The Spectranetics Corporation (NASDAQ: SPNC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4407-100free.

--
Brookdale Senior Living, Inc. Analyst Notes
On June 26, 2014, Brookdale Senior Living, Inc. (Brookdale) reported that together with Wish of a Lifetime™, the Company fulfilled the wish of an 87-year-old resident of Sterling House of Lancaster, a Brookdale senior living community, named Donna. In 2010, Wish of a Lifetime™ and Brookdale formed a partnership to provide a helping hand in making some of the dreams of Brookdale's residents come true. Donna was granted her wish to ride a Model T car again, which held fond memories of her childhood. The Company informed that since the inception of the partnership between the Company and Lifetime™, over 600 Brookdale seniors have had their wishes granted. The full analyst notes on Brookdale are available to download free of charge at:

http://www.analystsreview.com/Jul-03-2014/BKD/report.pdf

--
WellCare Health Plans, Inc. Analyst Notes
On June 25, 2014, WellCare Health Plans, Inc. (WellCare) announced that it will release its Q2 2014 results on July 31, 2014, at 6:30 a.m. ET, which will be followed by a conference call at 10:00 a.m. ET. According to the Company, the discussion, which will be led by WellCare's CEO Dave Gallitano, will be webcast live through its website. In addition, a replay of the webcast will be accessible approximately an hour after the completion of the live event and remain for 30 days at the Company's website. The full analyst notes on WellCare are available to download free of charge at:

http://www.analystsreview.com/Jul-03-2014/WCG/report.pdf

--
IDEXX Laboratories, Inc. Analyst Notes
On June 30, 2014, IDEXX Laboratories, Inc. (IDEXX) celebrated its 30th anniversary with an official ribbon-cutting ceremony at the Synergy Center in Westbrook - the new LEED® Gold Certified administrative office building. According to the Company, its Chairman and CEO Jonathan Ayers, along with Maine Governor Paul LePage, Westbrook Mayor Colleen Hilton, U.S. Representatives Chellie Pingree and Mike Michaud, and other officials celebrated the completion of IDEXX's $35 million expansion at its World Campus which will accommodate up to 300 employees. Further, IDEXX reported that it has added over 240 jobs since breaking ground two years ago and now employs over 2,100 people at its World Campus in Westbrook. The eco-friendly design of the new 107,700-square-foot three-story Synergy Center facility was granted with U.S. Green Building Council's Leadership in Energy and Environmental Design® (LEED®) Gold certification due to its use of natural lighting, energy-efficient systems, green roofing materials with low-toxin, locally sourced and largely recycled materials. The full analyst notes on IDEXX are available to download free of charge at:

http://www.analystsreview.com/Jul-03-2014/IDXX/report.pdf

--
Kindred Healthcare, Inc. Analyst Notes
On June 25, 2014, Kindred Healthcare, Inc. (Kindred) announced the closing of the underwritten public offering for an aggregate of 9.0 million shares of the Company's common stock. Further, the Company has granted the underwriters a 30-day option to purchase up to an additional 1.35 million shares of Kindred common stock. Kindred stated that the net proceeds from the offering will be used to finance potential acquisitions or for general corporate purposes, including the payment of its existing indebtedness. The full analyst notes on Kindred are available to download free of charge at:

http://www.analystsreview.com/Jul-03-2014/KND/report.pdf

--
The Spectranetics Corporation Analyst Notes
On June 30, 2014, The Spectranetics Corporation (Spectranetics) announced that it has completed the acquisition of AngioScore Inc., a developer, manufacturer, and marketer of cardiovascular specialty balloons, for $230 million in cash, along with additional contingent commercial and regulatory milestone payments. Scott Drake, President and CEO, Spectranetics said, "We are very excited to complete this important transaction. AngioScore meets our criteria with an exceptional strategic fit, leverageable call points, differentiated technology and clear operating efficiencies. With AngioScore now a part of our company, we have a meaningfully expanded market opportunity and a compelling product portfolio." The full analyst notes on Spectranetics are available to download free of charge at:

http://www.analystsreview.com/Jul-03-2014/SPNC/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com .

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com .

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review